{"status":"success","data":{"title":"Beta Agonist Therapy and Lactic Acidosis in Asthma","slug":"beta-agonist-lactic-acidosis","tags":null,"collection":["Pulmonology","Pharmacology","Toxicology"],"content":"<h1 id=\"beta-agonist-therapy-and-lactic-acidosis-in-asthma\">Beta Agonist Therapy and Lactic Acidosis in Asthma</h1>\n<p><strong>Is the rise in lactate expected following beta-agonist therapy? Is it significant?</strong></p>\n<p><strong>Main points</strong></p>\n<ul>\n<li>Inhaled and IV beta-agonists can contribute to lactic acidosis.</li>\n<li>Studies have reported lactate levels &gt;10 mmol/L. [<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=21802882\">Claret, 2012</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=18410827\">Creagh-Brown, 2008</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208\">Maury, 1997</a>]</li>\n<li>Asthmatics noted to have an elevated lactate level following beta-agonist therapy should have a thorough assessment for evidence of true tissue hypoperfusion before lactic acidosis is attributed entirely to beta-agonist therapy. </li>\n<li>While the use of continuous nebulized beta-agonist therapy is supported by <a href=\"http://www.nhlbi.nih.gov/guidelines/asthma/\">NIH&#39;s EPR-3</a>, patients requiring continuous nebulizers for more than a few hours should have a lactate checked. If a high lactate is found, clinicians should consider whether the rising lactate may be contributing to their patient’s respiratory distress and consider transitioning the patient to less frequent nebulized therapy.</li>\n</ul>\n<p><strong>Click <a href=\"http://academiclifeinem.com/lactic-acidosis-beta-agonist-therapy-asthma/\">here</a> for full ALiEM original post</strong></p>\n<h2 id=\"causes-of-lactic-acidosis-in-asthma\">Causes of lactic acidosis in asthma</h2>\n<p>A simple respiratory alkalosis is the most common acid-base disorder in acute asthma.[<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=2118447\">Mountain, 1990</a>] However, lactic acidosis is frequently identified especially in cases of severe asthma.[<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=778959\">Roncoroni, 1976</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=6414303\">Appel, 1983</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=23947392\">Raimondi, 2013</a>] </p>\n<p>Possible causes of lactic acidosis in asthma include:</p>\n<ul>\n<li>Tissue hypoxia due to hypoxemia and the decrease in venous return caused by elevated intrinsic PEEP</li>\n<li>Relative hepatic ischemia and impaired lactate clearance due to venous congestion</li>\n<li>Increased respiratory muscle work against constricted upper airways</li>\n<li>Beta-agonist therapy </li>\n</ul>\n<h2 id=\"beta-agonists-role-in-elevated-lactate\">Beta-agonists role in elevated lactate</h2>\n<p>Causes of lactic acidosis can be organized into two categories: [<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=11251027\">Luft, 2001</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=24079682\">Anderson, 2013</a>]</p>\n<ul>\n<li><strong>Type A:</strong> Secondary to tissue hypoxia: shock, cardiac arrest</li>\n<li><p><strong>Type B:</strong> Lactic acidosis without hypoxia. This can occur through several mechanisms.</p>\n<ol>\n<li>Impaired pyruvate dehydrogenase activity (e.g. thiamine deficiency)</li>\n<li>Increased production by neoplastic cells</li>\n<li>Medication-induced mitochondrial dysfunction (e.g. antiretroviral therapy, linezolid, propofol)</li>\n<li>Impaired conversion of lactate to glucose (e.g. hepatic dysfunction)</li>\n</ol>\n</li>\n</ul>\n<p>Lactic acidosis caused by β-agonist therapy is a <strong>type B lactic acidosis</strong>. The exact mechanism for the rise in lactate levels seen with beta-agonist therapy is unclear, but stimulation of beta-receptors causes a variety of metabolic effects which may increase lactate production including: [<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=1353501\">Haffner, 1992</a>]</p>\n<ul>\n<li>Increased glycogenolysis and glycolysis</li>\n<li>Increased lipolysis leading to a rise in fatty acids levels which can inhibit conversion of pyruvate to acetyl-CoA</li>\n</ul>\n<h2 id=\"beta-agonists-induced-lactic-acidosis\">Beta-agonists-induced lactic acidosis</h2>\n<p>Two small prospective studies have addressed this issue:</p>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=15911945\">Rodrigo et al. Emerg Med J 2005</a><ul>\n<li>Enrolled 18 patients with acute severe asthma treated with albuterol 0.4 mg via inhaler every 10 minutes for 2 hours.</li>\n<li>Lactate levels were drawn at baseline and following treatment<strong>. </strong></li>\n<li>At baseline, all patients had a lactate level &lt;2.2 mmol/L.</li>\n<li>Following treatment, the mean plasma lactate 2.9 mmol/L (significantly higher than baseline) and 4 patients had a lactate of ≥4 mmol/L.</li>\n</ul>\n</li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=9609407\">Rabbat et al. Int Care Med 1998</a><ul>\n<li>Enrolled 29 patients admitted to an ICU with acute severe asthma.</li>\n<li>All patients received protocolized asthma care including frequent salbutamol 10 mg nebulizers and IV salbutamol 1 mg/hr. </li>\n<li>On admission to the ICU, the mean arterial lactate was 3.11 mmol/L (range 1.1-10.4)</li>\n<li>Six hours following admission, arterial lactate levels increased in all patients to a mean of 7.4 mmol/L (2.6-16). The average lactate rise was 4.6 mmol/L. </li>\n<li>An elevated lactate was not found to have any prognostic significance.</li>\n</ul>\n</li>\n</ul>\n<p>Multiple case reports have described a rise in lactate following either inhaled or IV beta-agonist therapy for acute asthma.[<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=21802882\">Claret, 2012</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=18410827\">Creagh-Brown, 2008</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208\">Maury, 1997</a>] Importantly, several case reports have described beta-agonist therapy paradoxically worsening an asthmatic’s clinical course as they struggle to compensate for the rising lactic acidosis.[<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208\">Maury, 1997</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=22613097\">Dodda, 2012</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=12068341\">Prakash, 2002</a>]</p>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=12068341\">Prakash S, Mehta S. Lactic acidosis in asthma: report of two cases and review of the literature. Can Respir J. May-Jun 2002;9(3):203-208.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=9609407\">Rabbat A, Laaban JP, Boussairi A, Rochemaure J. Hyperlactatemia during acute severe asthma. Intensive Care Med. Apr 1998;24(4):304-312.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=21802882\">Claret PG, Bobbia X, Boutin C, Rougier M, de la Coussaye JE. Lactic acidosis as a complication of beta-adrenergic aerosols. Am J Emerg Med. Sep 2012;30(7):1319 e1315-1316.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=23947392\">Raimondi GA, Gonzalez S, Zaltsman J, Menga G, Adrogue HJ. Acid-base patterns in acute severe asthma. J Asthma. Dec 2013;50(10):1062-1068.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=6414303\">Appel D, Rubenstein R, Schrager K, Williams MH, Jr. Lactic acidosis in severe asthma. Am J Med. Oct 1983;75(4):580-584.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=9187208\">Maury E, Ioos V, Lepecq B, Guidet B, Offenstadt G. A paradoxical effect of bronchodilators. Chest. Jun 1997;111(6):1766-1767.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=11251027\">Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol. Feb 2001;12 Suppl 17:S15-19.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=18410827\">Creagh-Brown BC, Ball J. An under-recognized complication of treatment of acute severe asthma. Am J Emerg Med. May 2008;26(4):514 e511-513.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=2118447\">Mountain RD, Heffner JE, Brackett NC, Jr, Sahn SA. Acid-base disturbances in acute asthma. Chest. Sep 1990;98(3):651-655.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=15911945\">Rodrigo GJ, Rodrigo C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J. Jun 2005;22(6):404-408.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=778959\">Roncoroni AJ, Adrougue HJ, De Obrutsky CW, Marchisio ML, Herrera MR. Metabolic acidosis in status asthmaticus. Respiration. 1976;33(2):85-94</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=24079682\">Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc. Oct 2013;88(10):1127-1140.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=1353501\">Haffner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther. Jun 1992;17(3):155-164.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=22613097\">Dodda VR, Spiro P. Can albuterol be blamed for lactic acidosis? Respir Care. Dec 2012;57(12):2115-2118.</a></li>\n</ul>\n"}}